NEW YORK (GenomeWeb) – Cynvenio Biosystems said today that it has signed four new distribution agreements for its ClearID line of liquid biopsy tests, making the assays available immediately for patients in Israel, Greece, Argentina, and South Korea.

Pronto Diagnostics will market ClearID in Israel, Karyo in Greece, ProgeniTest in Argentina, and Bio-Medical Science in South Korea.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.